![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NEW ONCE-DAILY ORAL DIABETES TREATMENT GLUMETZA NOW AVAILABLE
NEW ONCE-DAILY ORAL DIABETES TREATMENT GLUMETZA NOW AVAILABLE
Adult patients living with type 2 diabetes now have a new treatment option available that may help them get the most out of their care. King Pharmaceuticals, Inc. and Depomed, Inc. announced the commercial availability of Glumetza (metformin
hydrochloride extended release tablets) in the United States. Glumetza, an oral
treatment for type 2 diabetes, offers the benefits of metformin, including reliable
glycemic control, absence of weight gain, and a low incidence of hypoglycemia,
with the added convenience of once-daily dosing.
Genetic
Engineering News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct